Please login to the form below
J&J gets EU green light for novel TB drug
Sirturo approved to treat multidrug resistant form of the disease
Novartis' dermatology plans advance with Xolair approval
Green light for use in chronic spontaneous urticaria
Diabetes awards programme launches
QiC Diabetes 2014 premiered at Diabetes UK conference
INC Research acquires Middle Eastern CRO
BMS' novel HIV drug clears phase II trial
Entry inhibitor BMS-660368 moves closer to first-in-class approval
Lilly/Boehringer's empagliflozin faces US approval delay
FDA cites manufacturing issues with the new diabetes drug
UDG buys KnowledgePoint360’s comms business
Deal is worth $144m
Edelman extends PR contract with Leo Pharma
Will continue to work together in Germany
Translational pharmacology: the key to ensuring safe and effective dosing
Designing pharmacokinetic and toxicokinetic studies during preclinical and early phase 1 trials will maximise a candidate’s chance of safety and efficacy success
-
Use data responsiblyIt’s imperative that opening up clinical trial data doesn’t compromise patient safety
-
Pharma’s four options for innovationOnly genuinely creative companies will profit from the future
-
Eisai and Biogen partner on Alzheimer’sWill co-develop two drug candidates
-
Generic for Lilly's Evista in US 'within a month'Teva to launch copy of osteoporosis drug
-
NICE relents and backs Pfizer's InlytaRecommends drug to treat advanced kidney cancer on NHS in England
-
NHS promotes better drug understanding‘My Medicines, My Health’ kicks off in north east England
-
KCR expanding into the UK and Germany
Contract research organisation registers two new entities
-
Teva launches first inhaled antipsychotic in USAdasuve available for the treatment of agitation associated with schizophrenia or bipolar disorder
-
NICE: Alexion must justify Soliris' high costUK body unable to recommend ‘ultra-orphan’ drug
Latest appointments
-
Stallergenes appoints Christian Chavy CEOHe will replace Roberto Gradnik at the end of this month
-
New VP for Merz North AmericaGregory Bass to lead market access and reimbursement strategy
-
Vansen Pharma appoints new president and CEO
Ahmad Doroudian was CEO of Merus Labs International
-
Novasep appoints board chairmanCEO Michel Spagnol takes on dual role
-
AstraZeneca loses comms headNeil McCrae to join UK’s Royal Mail
Featured jobs
- Planning Director
- Circa £100,000 with Extensive Package
- Senior Marketing Consultant - Leading Consultancy - Surrey
- Excellent Basic, Bonus + Benefits
- Account Director- Healthcare
- Highly Competitive Salary
- Account Director - Medical Education
- Competitive + excellent benefits
- Account Manager - Healthcare PR/ Comms
- £Competitive + excellent benefits
- Marketing Manager UK & Ireland - Bagshot, Surrey
- Circa £60,000 + benefits
- Senior Account Executive / Account Manager - Healthcare Advertising - London
- £30000 - £39000 + Bonus + Benefits
- Business Development Director
- Competitive Salary Offered
- Account Associate
- On application
- Brand Manager - Oncology - South East
- Excellent Basic, Bonus and Benefits
- Senior Production Editor opportunity in Oxfordshire. Salary up to £65, 000.
- Salary up to £65,000
- Account Manager / (Senior) Analyst – Market Access
- Up to £45,000 plus bonus
- Client Director, Healthcare, Dublin
- Competitive salary, plus benefits
Subscribe to our email news alerts
Latest intelligence
- Trust is key to online engagement
- In social media it underlines the value of HCP networks...
- Compulsory evaluation in France
- French authorities will expect robust health economic cases to be made for some drugs...
- Biosimilars: friend or foe for healthcare systems?
- They present a significant opportunity in Europe, but achieving widespread acceptance and uptake of biosimilars is by no means a done deal...
Quick links
